Does Hippocampal-Avoidance Whole-Brain Radiotherapy for Brain Metastases Meaningfully Change Current Practice?

Affiliations

Comment

Marc C Chamberlain. J Clin Oncol. 2015.

. 2015 Jun 10;33(17):1985.

doi: 10.1200/JCO.2014.60.4769. Epub 2015 Apr 20.

¹ University of Washington; Fred Hutchinson Cancer Research Center; and Seattle Cancer Care Alliance, Seattle, WA chambemc@u.washington.edu.

No abstract available

Comment in

Reply to M.C. Chamberlain.
Gondi V, Tome WA, Mehta MP. Gondi V, et al. J Clin Oncol. 2015 Jun 10;33(17):1986. doi: 10.1200/JCO.2015.60.9297. Epub 2015 Apr 20. J Clin Oncol. 2015. PMID: 25897163 No abstract available.
Reply to M.C. Chamberlain.
Kotecha R, Suh JH. Kotecha R, et al. J Clin Oncol. 2015 Jun 10;33(17):1986-7. doi: 10.1200/JCO.2015.60.9305. Epub 2015 Apr 20. J Clin Oncol. 2015. PMID: 25897164 No abstract available.

Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial.
Gondi V, Pugh SL, Tome WA, Caine C, Corn B, Kanner A, Rowley H, Kundapur V, DeNittis A, Greenspoon JN, Konski AA, Bauman GS, Shah S, Shi W, Wendland M, Kachnic L, Mehta MP. Gondi V, et al. J Clin Oncol. 2014 Dec 1;32(34):3810-6. doi: 10.1200/JCO.2014.57.2909. Epub 2014 Oct 27. J Clin Oncol. 2014. PMID: 25349290 Free PMC article. Clinical Trial.